Donanemab | Patient completes infusion

Media Contact: Susan Gregg - 206-390-3226, sghanson@uw.edu


UW Medicine patient David Park rests after completing his infusion of donanemab to treat Alzheimer's disease in April 2025 at Harborview Medical Center in Seattle.  See associated news release